The Atlantic on the ongoing efforts in the Senate to pass a bipartisan “improvement bill” to stabilize Obamacare insurance exchanges:
“The hearings are the brainchild of Senator Lamar Alexander of Tennessee, the Republican chairman of the Health, Education, Labor, and Pensions Committee, who has been talking for months about the need to stabilize Obamacare’s individual insurance market…Alexander, aides said, has an ambitious goal of moving quickly from hearings to drafting legislation that would, at minimum, guarantee the continued payment of cost-sharing reduction subsidies to insurance companies and allow states more flexibility to adjust insurance rules…”
Continue reading Health Policy Updates: September 2 2017
There was a new study out this week in JAMA Internal Medicine assessing the impact of Accountable Care Organization on health care spending. The ACO model of reimbursement, with the ACA/Obamacare has supported the growth of, is a form of capitation. The idea is that if health systems get paid for the overall care of each patient but not for each additional test it performs, then the financial incentive to order more tests will decrease, as will overall spending.
That is indeed what this study found, though the effect was modest – about $136 per patient per year. Continue reading Health Policy Updates: August 27 2016
A new study published in JAMA Internal Medicine this week had some surprising findings relating to gifts to physicians from pharmaceutical companies. The authors asked whether physicians who received a free meal from a drug company were more likely to prescribe expensive, brand-name medications produced by that company. The answer – surprisingly or not – was “yes.” And, it remained “yes” even for single meals less that $20 in value (though the association tended to be higher for more and/or more expensive meals). This study has obvious implications regarding the ethics of physician-industry financial relationships.
“The differences persisted after controlling for prescribing volume and potential confounders such as physician specialty, practice setting, and demographic characteristics. Furthermore, the relationship was dose dependent, with additional meals and costlier meals associated with greater increases in prescribing of the promoted drug. Our findings were consistent across 4 brand-name drugs, including rosuvastatin…” Continue reading Health Policy Updates: June 25 2016
Growth in health care spending, low for the past several years for reasons that are still unclear, has been increasing again. This is reflected in a new projection of health care spending over the next decade.
“Recent historically low growth rates in the use of medical goods and services, as well as medical prices, are expected to gradually increase.” Continue reading Health Policy Updates: September 19 2015
News this week on the progress of ACOs, a new payment model that the ACA is experimenting with. The idea is that health care providers makes something like a flat rate for taking care of a given set of patients. If they do so for less money than expected, they get to keep the difference; if they spend too much, then they lose money. Obviously, the goal here is to cut health care costs by moving away from the fee-for-service payment model that incentivizes increased spending. Several ACOs have been up and running, and results on their performance are starting to come in.
Austin Frakt at TheUpshot reports on two recent studies here. Continue reading Health Policy Updates: July 5 2015